Javier Moreno

Javier Moreno

Auto-generated profile, based on publicly available information

Javier Moreno

Arrhythmia Unit, Hospital Universitario Ramón y Cajal , Madrid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2014 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
JMJavier Moreno
Javier Moreno
JQJorge G. Quintanilla
Jorge G. Quintanilla
RMRoberto Molina‐Morúa
Roberto Molina‐Morúa
MGMaría Jesús García‐Torrent
María Jesús García‐Torrent
MAMaría José Angulo‐Hernández
María José Angulo‐Hernández
JPJulián Pérez‐Villacastín
Julián Pérez‐Villacastín

4 June 2024 in EP Europace
Verified
Journal Article
Open access
PDF file
JTJohanna Tonko
Johanna Tonko
CLCristina Lozano
Cristina Lozano
JMJavier Moreno
Javier Moreno
ACAnthony Chow
Anthony Chow
MDMehul Dhinoja
Mehul Dhinoja
PLPier D Lambiase
Pier D Lambiase
Successful ventricular arrhythmia (VA) ablation requires identification of functionally critical sites during contact mapping. Estimation of the peak frequency (PF) component of the electrogram (EGM) may improve correct near-field (NF) annotation to identify circuit segments on the mapped surface. In turn, assessment of NF and far-field (FF) EGMs may delineate the three-dimensional path of a ventricular tachycardia (VT) circuit. A proprietary NF detection algorithm was applied retrospectively to scar-related re-entry VT maps and compared with manually reviewed maps employing first deflection (FDcorr) for VT activation maps and last deflection (LD) for substrate maps. Ventricular tachycardia isthmus location and characteristics mapped with FDcorr vs. NF were compared. Omnipolar low-voltage areas, late activating areas, and deceleration zones (DZ) in LD vs. NF substrate maps were compared. On substrate maps, PF estimation was compared between isthmus and bystander sites. Activation mapping with entrainment and/or VT termination with radiofrequency (RF) ablation confirmed critical sites. Eighteen patients with high-density VT activation and substrate maps (55.6% ischaemic) were included. Near-field detection correctly located critical parts of the circuit in 77.7% of the cases compared with manually reviewed VT maps as reference. In substrate maps, NF detection identified deceleration zones in 88.8% of cases, which overlapped with FDcorr VT isthmus in 72.2% compared with 83.3% overlap of DZ assessed by LD. Applied to substrate maps, PF as a stand-alone feature did not differentiate VT isthmus sites from low-voltage bystander sites. Omnipolar voltage was significantly higher at isthmus sites with longer EGM durations compared with low-voltage bystander sites. The NF algorithm may enable rapid high-density activation mapping of VT circuits in the NF of the mapped surface. Integrated assessment and combined analysis of NF and FF EGM-components could support characterization of three-dimensional VT circuits with intramural segments. For scar-related substrate mapping, PF as a stand-alone EGM feature did not enable the differentiation of functionally critical sites of the dominant VT from low-voltage bystander sites in this cohort. Left top: LAT emphasis maps in VT activation mapping—Exemplary VT LAT maps with LAT-on-LAT emphasis in a RV VT and LV VT to highlight diastolic potentials. Left bottom: Example of left ventricular substrate map in a patient with extensive chronic anterior myocardial infarct (left, grey < 0.1 mV, purple > 1.5 mV) with emphasis on high-frequency EGMs (middle, emphasizing EGMs with >250 Hz) and visualization of peak frequency values (right, with nominal thresholds of EnSite X: grey < 200 Hz, white > 250 Hz). Right: Schematic illustration of how integration of NF and FF information may allow to distinguish two- and three-dimensional VT circuits and estimate the three-dimensional path of the VTCC. Yet, important confounders for using NF and peak frequency in ventricular mapping exist and need to be considered. 2D, two-dimensional; 3D, three-dimensional; EGM, electrogram; ICM, ischaemic cardiomyopathy; FF, far field; LV, left ventricle; NF, near field; RV, right ventricle; VT, ventricular tachycardia.

1 April 2017 in Heart Rhythm
Verified
Journal Article
Open access
AHAntonio Hernández‐Madrid
Antonio Hernández‐Madrid
DFDomenico Facchin
Domenico Facchin
RKRuth Nicholson Klepfer
Ruth Nicholson Klepfer
SGSubham Ghosh
Subham Ghosh
RMRoberto Matía
Roberto Matía
ALAlessandro Locatelli
Alessandro Locatelli
A high percentage of biventricular (BiV) or left ventricular (LV) pacing in cardiac resynchronization therapy (CRT) devices has been associated with superior clinical outcomes. However, the percent ventricular (%V) pacing reported by CRT devices simply indicates the number of paces the device has delivered and not the proportion of pacing that has captured the LV effectively. The purpose of this study was to determine whether a beat-by-beat evaluation of effective pacing would provide a more accurate evaluation of CRT delivery. An automatic electrogram (EGM)-based algorithm that classifies each LV pace as effective or ineffective based on detection of QS/QS-r morphology on the unipolar LV EGM during pacing was developed and validated. LV EGMs that were recorded by 24-hour Holter from 57 CRT patients were postprocessed. The percent effective CRT (%e-CRT) pacing was calculated by dividing the time spent in e-CRT pacing by the total time of the recording. In this CRT cohort, the average %V pacing (94.8% ± 8%) significantly overestimated the %e-CRT pacing (87.5% ± 23%; P <.001). A significant minority of subjects (18%) had a discrepancy of at least 3 percentage points between %V pacing and %e-CRT pacing (mean 39% ± 41%). Current device pacing diagnostics overestimate the amount of CRT pacing actually delivered. The new algorithm quantifies ineffective CRT pacing, which enables clinicians to identify patients with this issue and to address the reasons behind suboptimal CRT delivery.

1 August 2024 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Open access
JTJohanna Tonko
Johanna Tonko
ACAnthony Chow
Anthony Chow
CLCristina Lozano
Cristina Lozano
JMJavier Moreno
Javier Moreno
PLPier D. Lambiase
Pier D. Lambiase

12 January 2018 in Entropy
Verified
Journal Article
Open access
PDF file
RARaquel Cervigon Abad
Raquel Cervigon Abad
FCFrancisco Castells
Francisco Castells
JGJosé Gómez-Pulido
José Gómez-Pulido
JPJulián Pérez-Villacastín
Julián Pérez-Villacastín
JMJavier Moreno
Javier Moreno
Atrial fibrillation (AF) is already the most commonly occurring arrhythmia. Catheter pulmonary vein ablation has emerged as a treatment that is able to make the arrhythmia disappear; nevertheless, recurrence to arrhythmia is very frequent. In this study, it is proposed to perform an analysis of the electrical signals recorded from bipolar catheters at three locations, pulmonary veins and the right and left atria, before to and during the ablation procedure. Principal Component Analysis (PCA) was applied to reduce data dimension and Granger causality and divergence techniques were applied to analyse connectivity along the atria, in three main regions: pulmonary veins, left atrium (LA) and right atrium (RA). The results showed that, before the procedure, patients with recurrence in the arrhythmia had greater connectivity between atrial areas. Moreover, during the ablation procedure, in patients with recurrence in the arrhythmial both atria were more connected than in patients that maintained sinus rhythms. These results can be helpful for procedures designing to end AF.

6 May 2026 in EP Europace
Verified
Journal Article
Open access
MMMartin Manninger
Martin Manninger
USUniv.-Prof. Priv.-Doz. Dr.med.univ. Daniel Scherr
Univ.-Prof. Priv.-Doz. Dr.med.univ. Daniel Scherr
ABAlan Bulava
Alan Bulava
JKJonathan Kalman
Jonathan Kalman
PSPrashanthan Sanders
Prashanthan Sanders
John SilberbauerJohn Silberbauer
John Silberbauer
Aims: A dual-energy ablation system was developed to optimize targeted energy delivery via a flexible-tip, contact-force sensing catheter with electroanatomic mapping integration. This is the first report of long-term safety and effectiveness results of this system for ablation of paroxysmal atrial fibrillation (PAF). Methods and results: The FOCALFLEX study is a prospective, multicentre study. Patients with PAF were enrolled between August 2024 and January 2025, with 144 patients (62.0 ± 10.0 years, 62.6% male) undergoing ablation with the TactiFlex PFA System at 21 sites worldwide. Primary safety and effectiveness endpoints were the rate of pre-defined serious adverse events within 7 days and the 6-month freedom from documented AF/AFL/AT episodes >30 s after a 90-day blanking period. Pulmonary vein isolation (PVI) was performed in each case with pulsed field required for posterior left atrium (LA) ablation and radiofrequency (RF) for cavotricuspid isthmus or near coronary arteries. Non-PV targets and modality were at physician’s discretion. Acute effectiveness was confirmed via entrance block and post-ablation LA voltage map after a 20-min waiting period and was achieved in 99.6% (566/568) of treated PVs with 95.5 ± 37.1 pulsed field ablation (PFA) applications/patients. Procedure, fluoroscopy, LA dwell, and PV ablation times were 112.2 ± 29.5, 7.6 ± 5.7, 81.1 ± 19.7, and 47.4 ± 16.4 min, respectively. There were two (1.4%) primary safety events. At 6 months, 81.0% of subjects were free from documented arrhythmia recurrence and the protocol-defined primary effectiveness rate was 79.6%. There was one repeat ablation (0.7%) after the blanking period through 6 months. Conclusion: The FOCALFLEX study results demonstrate safety and effectiveness of a novel dual-mode RF/PFA system through 6 months of follow-up to treat symptomatic, recurrent PAF. Clinical trial registration: ClinicalTrials.gov Identifier: NCT06271967